A method of conducting therapeutic sessions with mdma

Journal of Psychoactive Drugs

Volumn 30, Issue 4, 1998, Pages 371-379

  Greer, George R ^a   Tolbert, Requa ^b  

^a Heffter Research Institute   (United States)

^b NONE   (United States)

Author keywords

4 methylenedioxyamphetamine; Alternative medicine; Drug therapy; Intractable pain; N Methyl 3; Psychotherapy; Therapeutics

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; CASE REPORT; DOSE RESPONSE; FEAR; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INFORMED CONSENT; MALE; MYELOMA; PATIENT COUNSELING; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY;

EID: 0032427042     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1998.10399713     Document Type: Article

References (17)

1. Adamson, S. 1985. Through the Gateway of the Heart: Accounts of Experiences with MDMA and Other Empathogenic Substances. San Francisco: Four Trees Publications.
2. Beck, J. & Rosenbaum, M. 1994. Pursuit of Ecstasy: The MDMA Experience. Albany: SUNY Press.
3. Coccaro, E.F.; Kavoussi, R.J.; Cooper, T.B. & Hauger, R.L. 1997. Central serotonin activity and aggression: Inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. American Journal of Psychiatry 154 (10): 1430-5.
4. Cohen, R. 1998. The Love Drug: Marching to the Beat of Ecstasy. Binghamton, New York: Haworth Medical Press.
5. Dossey, L. 1993. Healing Words: The Power of Prayer and the Practice of Medicine. San Francisco: Harper San Francisco.
6. Dowling, G.P.; McDonough, E.T. 3rd & Bost, R.O. 1987. "Eve” and "Ecstasy”: A report of five deaths associated with the use of MDEA and MDMA. Journal of the American MedicalAssociation 27 (12): 1615-7.
7. Fenelon, F. ca. 1700. Untitled prayer.
8. Gasser, P. 1995. Psycholytic therapy with MDMA and LSD in Switzerland. Bulletin of the Multidisciplinary Association for Psychedelic Studies 5 (3): 3-7. (Full text at http://www.maps.org/news-letters/v05n3/05303psy.html.)
9. Greer, G. & Tolbert, R. 1990. The therapeutic use of MDMA. In: S.J. Peroutka (Ed.) Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Norwell, Massachusetts: Kluwer Academic Publishers.
10. Greer, G. & Tolbert, R. 1986. Subjective reports of the effects of MDMA in a clinical setting. Journal of Psychoactive Drugs 18(4): 319-27. (Full text at http://www.heffter.org/SUBJREPT.HTML.)
11. Grinspoon, L. & Bakalar, J. 1979. Psychedelic Drugs Reconsidered. New York: Basic Books.
12. Grob, C.S. & Poland, R.E. 1997. MDMA. In: J.H. Lowinson; P. Ruiz; R.B. Millman & J G. Langrod (Eds.) Substance Abuse: A Comprehensive Textbook. Third Ed. Baltimore: Williams & Wilkins.
13. Grof, S. 1994. LSD Psychotherapy. Alameda, California: Hunter House.
14. McCann, U.D.; Ridenour, B.S.; Shaham, Y. & Ricaurte, G.A. 1994. Serotonin neurotoxicity after (+/-) 3,4 methylenedioxymethamphetamine (MDMA; "ecstasy"): A controlled study in humans. Neuropsychopharmacology 10:129-38.
15. Saunders, N. & Doblin, R. 1996. Ecstasy: Dance, Trance and Transformation. Oakland, California: Quick American Archives.
16. Solowij, N.; Hall, W. & Lie, N. 1992. Recreational MDMA use in Sydney: a profile of “Ecstasy" users and their experiences with the drug. British Journal of Addictions 87:1161-72.
17. Wolfson, P.E. 1986. Meetings at the edge with Adam: A man for all seasons? Journal of Psychoactive Drugs 18 (4): 329-33.